Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/9469
Title: Effect of mud compress therapy on cartilage destruction detected by CTX-II in patients with knee osteoarthritis
Authors: Gungen, G.O.
Ardıç, Füsun
Fındıkoğlu,Gülin
Rota, Simin
Keywords: balneotherapy
Biomarker
bone
CTX-II
spa
subchondral
carboxy terminal telopeptide
collagen type 2
biological marker
C-terminal cross-linking telopeptide of type II collagen, human
peptide fragment
adult
aged
Article
body mass
cartilage degeneration
comparative effectiveness
compression therapy
conservative treatment
disease severity
female
follow up
hot pack therapy
human
knee osteoarthritis
knee pain
major clinical study
male
mud compress therapy
pain assessment
pain intensity
physical activity
postmenopause
priority journal
visual analog scale
articular cartilage
comparative study
knee
middle aged
mud therapy
Osteoarthritis, Knee
pathophysiology
urine
Aged
Biomarkers
Cartilage, Articular
Collagen Type II
Female
Humans
Knee Joint
Male
Middle Aged
Mud Therapy
Peptide Fragments
Visual Analog Scale
Publisher: IOS Press
Abstract: BACKGROUND/OBJECTIVE: The aim of this study is to investigate the effect of mud compress (MC) therapy compared to hot pack (HP) therapy on cartilage destruction and subchondral bone alterations detected by urine levels of C telopeptide fragment of collagen type-II (uCTX-II) in patients with knee osteoarthritis (OA). METHODS: Fifty-nine patients between 49-74 years of age with bilateral knee OA divided into 2 groups. Twenty-five patients (16 females, 9 males) and 34 patients (22 females, 13 males) were given HP versus local natural organic and mineral-rich MC therapy respectively for 2 weeks as a total of 12 sessions. uCTX-II, Visual Analog Scale (VAS), 15 m walking time, Western Ontario and McMaster Universities multifunctional (WOMAC) index were measured at baseline, after-treatment and 3 months after treatment. RESULTS: uCTX-II level did not show any difference between the two groups, however it decreased significantly in MC and HP groups 3 months after treatment (p< 0.017). WOMAC stiffness sore was significantly lower in MC group 3 months after treatment (p< 0.05). Both MC and HP therapies lowered VAS, WOMAC total and subscores significantly up to 3 months (p< 0.017). CONCLUSIONS: HP and MC therapies for OA of knee are not superior to one another with respect to the level of uCTX-II. MC may probably decrease the ongoing cartilage destruction and related subchonral bone interactions earlier compared to HP treatment in patients with knee OA as evidenced by decreased uCTX-II levels after-treatment. © 2016 IOS Press and the authors.
URI: https://hdl.handle.net/11499/9469
https://doi.org/10.3233/BMR-150629
ISSN: 1053-8127
Appears in Collections:PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection
Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection

Show full item record



CORE Recommender

SCOPUSTM   
Citations

13
checked on Jul 29, 2024

WEB OF SCIENCETM
Citations

11
checked on Jul 31, 2024

Page view(s)

68
checked on Jul 31, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.